The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Open accessAbstract
BACKGROUND: Resistance to triazoles was recently reported in Aspergillus fumigatus isolates cultured from patients with invasive aspergillosis. The prevalence of azole resistance in A. fumigatus is unknown. We investigated the prevalence and spread of azole resistance using our culture collection that contained A. fumigatus isolates collected between 1994 and 2007. METHODS AND FINDINGS: We investigated the prevalence of itraconazole (ITZ) resistance in 1,912 clinical A. fumigatus isolates collected from 1,219 patients in our University Medical Centre over a 14-y period. The spread of resistance was investigated by analyzing 147 A. fumigatus isolates from 101 patients, from 28 other medical centres in The Netherlands and 317 isolates from six other countries. The isolates were characterized using phenotypic and molecular methods. The electronic patient files were used to determine the underlying conditions of the patients and the presence of invasive aspergillosis. ITZ-resistant isolates were found in 32 of 1,219 patients. All cases were observed after 1999 with an annual prevalence of 1.7% to 6%. The ITZ-resistant isolates also showed elevated minimum inhibitory concentrations of voriconazole, ravuconazole, and posaconazole. A substitution of leucine 98 for histidine in the cyp51A gene, together with two copies of a 34-bp sequence in tandem in the gene promoter (TR/L98H), was found to be the dominant resistance mechanism. Microsatellite analysis indicated that the ITZ-resistant isolates were genetically distinct but clustered. The ITZ-sensitive isolates were not more likely to be responsible for invasive aspergillosis than the ITZ-resistant isolates. ITZ resistance was found in isolates from 13 patients (12.8%) from nine other medical centres in The Netherlands, of which 69% harboured the TR/L98H substitution, and in six isolates originating from four other countries. CONCLUSIONS: Azole resistance has emerged in A. fumigatus and might be more prevalent than currently acknowledged. The presence of a dominant resistance mechanism in clinical isolates suggests that isolates with this mechanism are spreading in our environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment
Kumar, S. (2004) · Briefings in Bioinformatics · doi:10.1093/bib/5.2.150 · Cited by 11,756
Glass, N. L., & Donaldson, G. C. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.4.1323-1330.1995 · Cited by 4,755
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
High resolution of human evolutionary trees with polymorphic microsatellites
Bowcock, A. M., Ruiz-Linares, A., Tomfohrde, J., Minch, E., Kidd, J. R., & Cavalli-Sforza, L. L. (1994) · Nature · doi:10.1038/368455a0 · Cited by 1,850
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Upton, A., Kirby, K. A., Carpenter, P., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 514
Itraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 508
Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490 · cited 5×
“1,2 , Henrich A. L. van der Lee 1,2 , Judith Kuijpers 1,2 , Anthonius J. M. M. Rijs 1,2 , János Varga 3,4 , Robert A. Samson 3 , Emilia Mellado 5 , A. Rogier T. Donders 6 , Willem J. G. Melchers 1,2 , Paul E. Verweij 1,2* 1 Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The…”
InfluentialSelf-citationMechanisms of resistance to fungicides in field strains of Botrytis cinerea
Leroux, P., Fritz, R., Debieu, D., Albertini, C., Lanen, C., Bach, J., Gredt, M., & Chapeland, F. (2002) · Pest Management Science · doi:10.1002/ps.566 · Cited by 483
Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus
Balajee, S. A., Gribskov, J. L., Hanley, E., Nickle, D., & Marr, K. A. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.3.625-632.2005 · Cited by 404
Multiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Self-citationEvolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375
Mellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2431-2438.2001 · Cited by 307
Self-citationPolyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya
Samson, R. A., Hong, S., Peterson, S. W., Frisvad, J. C., & Varga, J. (2007) · Studies in Mycology · doi:10.3114/sim.2007.59.14 · Cited by 259
Self-citationde Valk, H. A., Meis, J. F. G. M., Curfs, I. M., Muehlethaler, K., Mouton, J. W., & Klaassen, C. H. W. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.4112-4120.2005 · Cited by 247
Molecular Studies Reveal Frequent Misidentification of Aspergillus fumigatus by Morphotyping
Balajee, S. A., Nickle, D., Varga, J., & Marr, K. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.00162-06 · Cited by 207
Self-citationMulti-azole resistance in Aspergillus fumigatus
Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 203
Chen, J., Li, H., Li, R., Bu, D., & Wan, Z. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh507 · Cited by 198
Critical Annotations to the Use of Azole Antifungals for Plant Protection
Hof, H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.2987-2990.2001 · Cited by 164
Acquired itraconazole resistance in Aspergillus fumigatus
Dannaoui, É. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 144
Warris, A., Klaassen, C. H. W., Meis, J. F. G. M., de Ruiter, M. T., de Valk, H. A., Abrahamsen, T. G., Gaustad, P., & Verweij, P. E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4101-4106.2003 · Cited by 141
Self-citationRajfer, J. (2016) · Physics Today · doi:10.1063/pt.5.031335 · Cited by 137
Hodiamont, C. J., Dolman, K. M., ten Berge, I. J. M., Melchers, W. J. G., Verweij, P. E., & Pajkrt, D. (2008) · Medical Mycology · doi:10.1080/13693780802545600 · Cited by 135
Self-citationVerweij, P. E., Dorsthorst, D. T. A. T., Rijs, A. J. M. M., de Vries-Hospers, H. G., & Meis, J. F. G. M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2648-2650.2002 · Cited by 108
Self-citationChryssanthou, E. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709011864 · Cited by 105
Keating, M. R., Guerrero, M., Daly, R. C., et al. (1996) · CHEST Journal · doi:10.1378/chest.109.4.1119 · Cited by 97
New taxa of Neosartorya and Aspergillus in Aspergillus section Fumigati
Hong, S., Shin, H., Hong, J., Frisvad, J. C., Nielsen, P. V., Varga, J., & Samson, R. A. (2007) · Antonie van Leeuwenhoek · doi:10.1007/s10482-007-9183-1 · Cited by 91
Self-citationMultidrug Resistance inAspergillus fumigatus
Warris, A., Weemaes, C. M. R., & Verweij, P. E. (2002) · New England Journal of Medicine · doi:10.1056/nejm200212263472618 · Cited by 86
Self-citationAzole and fungicide resistance in clinical and environmentalAspergillus fumigatusisolates
Meneau, I., & Sanglard, D. (2005) · Medical Mycology · doi:10.1080/13693780500090826 · Cited by 72
Pegues, D. A., Lasker, B. A., McNeil, M. M., Hamm, P. M., Lundal, J. L., & Kubak, B. (2002) · Clinical Infectious Diseases · doi:10.1086/338025 · Cited by 71
Aspergillosis—and a misleading sensitivity result
van Leer‐Buter, C., Takes, R. P., Hebeda, K. M., Melchers, W. J. G., & Verweij, P. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61055-1 · Cited by 40
Self-citation
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationAntifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Review of Antimicrobial Resistance in the Environment and Its Relevance to Environmental Regulators
Singer, A. C., Shaw, H., Rhodes, V., & Hart, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01728 · Cited by 844
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Metadata
- Authors
- Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-11-11
- Volume
- 5
- Issue
- 11
- Pages
- e219
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2012538966
- Cited by
- 727
- References
- 36
- FWCI
- 26.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.